AHUSD - Overview: Atypical Hemolytic Uremic Syndrome Complement Panel, Serum and Plasma

Detecting deficiencies in the alternative pathway that can cause atypical-hemolytic uremic syndrome, dense deposit disease, and C3 glomerulonephritis A second-tier test that aids in the differential diagnosis...

Mayo Clinic Laboratory and Pathology Research Roundup: April 30 - Insights

This week’s Research Roundup highlights a model for predicting breast cancer risk in women with atypical hyperplasia....

Thrombotic Microangiopathies (TMA) [Test in Focus] - Insights

Meera Sridharan, M.D., Ph.D., explains Mayo Clinic Labs’ testing approach for atypical hemolytic uremic syndrome (aHUS). The serological complement panel examines nine analytes to gain a thorough understanding...

Myasthenia Gravis [Test in Focus] - Insights

testing saves time and increases sensitivity and specificity to confirm diagnosis in patients with atypical presentation....

Optic Neuritis in the Era of Biomarkers - Insights

myelin oligodendrocyte glycoprotein (MOG) are recently described biomarkers seen in a subset of atypical optic neuritis which have revolutionized our understanding of the condition. In this “Hot Topic...